Dysregulation of microRNA (miRNA) expression has been implicated in molecular genetic events leading to the progression and development of atherosclerosis.
Cysteine peptidases have been implicated in molecular processes such as defense against root invasion by soil microorganisms, protein turnover to create new tissues, cellular homeostasis, and metabolism [ 34].
These experiments uncover a significant differential regulation of neurexin interactions with two different receptors through a splice code at two alternatively spliced segments that had not previously been implicated in molecular recognition events.
This protein contains a nitroxyl-terminal ligand-binding domain, which is implicated in molecular interactions, and a carboxyl-terminal phosphorylation domain, which accommodates the riboflavin molecule [ 27- 30].
The protein contains a nitroxyl-terminal (N-terminal) ligand-binding domain, which is implicated in molecular interactions, and a carboxyl-terminal (C-terminal) phosphorylated domain, which accommodates the riboflavin molecule [ 12– 15].
IPA analysis indicated that the potential targets for our set of regulated miRNAs are implicated in molecular functions related to EGF signaling such as cellular development, growth and proliferation; cell morphology and cell death and cell-to-cell-signaling and interaction [ 29], (Table 2).
In summary, our expression profile study identified a set of candidate genes which are implicated in molecular mechanisms that differentiate FAs from FVPTCs and thus, add to our knowledge of the tumor biology of these histopathologically related, but clinically distinct entities.
Recently, several TFs and miRNAs have been implicated in the molecular pathways linking EMT to the acquisition of stem cell properties, although the precise molecular circuitries remain largely undefined.
This is not unexpected, since both Uch37 and Rpn13 have been implicated in distinct molecular pathways presumably independent of their mutual interaction.
Although a number of transcription factors including cAMP response element binding protein (CREB) [18], [19], AP1 family members [20] [22], and Runx2 [23], [23] have been implicated in the molecular actions of PTH in osteoblasts, genetic studies have not strongly linked any of these factors in the anabolic actions of this hormone.
Twist1 has been implicated in several molecular pathways that are engaged in tumor progression, apoptosis and EMT.
